Lifespan.io vs AgingResearch.News
Choose Lifespan.io for
Readers who want written articles and interviews on rejuvenation research from the Lifespan Research Institute, and its hand-curated Rejuvenation Roadmap of therapies in development.
Choose AgingResearch.News for
Readers who want every new aging paper read and judged as it appears, the ones worth reading told in plain words each day, and the evidence on each drug, gene and process on one page.
Side by side
- What it is
- AgingResearch.News A reader of aging research: feeds, stories, evidence pages, news, trials and Ask
- Lifespan.io The news outlet of the Lifespan Research Institute: research, interviews, op-eds, the Rejuvenation Roundup and press releases1
- How often
- AgingResearch.News Stories every day, as the papers worth reading appear
- Lifespan.io About one news post a weekday: 21 posts from Sep 21 to Oct 19, 20262
- New papers
- AgingResearch.News Each new paper from PubMed, bioRxiv, medRxiv, arXiv and more, read as it appears and judged for what its own work shows about aging; about 1 in 20 reaches the feeds.
- Lifespan.io Articles on single studies, interviews and conference reports1
- Therapies
- AgingResearch.News A page for each drug with its stage toward patients, approvals and trials; Pro adds the pipeline
- Lifespan.io The Rejuvenation Roadmap: therapies by hallmark of aging and phase, updated Aug 21, 20263
- Price
- AgingResearch.News Free to read. Plus $12 a month or $99 a year; Pro, for company and pipeline intelligence, $59 a month.
- Lifespan.io Free to read; supported by donations, from $25 a month4
Where Lifespan.io is stronger
- Its articles include interviews with researchers and reports from conferences.
- The institute behind it also funds research, runs education programs and holds events.
- Its Rejuvenation Roadmap is a curated database of therapies in development, charting their progress by phase.
Where AgingResearch.News is different
- It reads every new aging paper as it appears, not a selection, and judges what each paper's own work shows about aging.
- Every card names the study in words, so a result in mice reads as one.
- Each drug, gene and process has a page that shows where its evidence stands: which species, whether independent labs found the same, what points the other way.
- Follow a subject and get an email when a new paper lands on it; Ask answers questions from the papers.
On AgingResearch.News now
On a typical day this past week, 4,300 new papers were read and 56 stories published, from a record of 706,959 papers.
- Cancer-promoting signals and immunity shape cell clearance in mice
Experiments in animals · Oct 20, 2026
- Face-photo predictions linked to mortality in cancer patients
Study in people · Oct 20, 2026
- Brain networks changed their relative balance as adults aged
Preprint: study in people · Oct 20, 2026
- Top
The day's most significant aging research, as stories
- Latest
Every paper that reached the feeds, newest first
- Rapamycin
An evidence page: species, independent labs, findings against, trials
- Trials
Clinical trials judged for what they mean for aging
- News
The field's news, told once per event, with the papers behind it
- Ask AgingResearch.News
Questions answered from the papers, every claim cited
Sources
Every fact about Lifespan.io above is from its own pages, read on the date given.
- 1. Lifespan.io: News, read Oct 20, 2026
- 2. Lifespan.io: its posts, with their dates, read Oct 20, 2026
- 3. Lifespan.io: The Rejuvenation Roadmap, read Oct 20, 2026
- 4. Lifespan.io: Lifespan Heroes, read Oct 20, 2026